S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
What is a Gold IRA, and is it a Viable Investment?
This Tech Stock Could be the Next Amazon (Ad)pixel
Closing prices for crude oil, gold and other commodities
MarketBeat Week in Review – 3/27 - 3/31
Modern Day Options Trading For Beginners! (Ad)pixel
UN body mulls deep sea mining amid demand for minerals
Intensity and insults rise as lawmakers debate debt ceiling
Modern Day Options Trading For Beginners! (Ad)pixel
UK travelers face hours-long waits for ferries to France
Canada approves largest telecom deal in country's history
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
What is a Gold IRA, and is it a Viable Investment?
This Tech Stock Could be the Next Amazon (Ad)pixel
Closing prices for crude oil, gold and other commodities
MarketBeat Week in Review – 3/27 - 3/31
Modern Day Options Trading For Beginners! (Ad)pixel
UN body mulls deep sea mining amid demand for minerals
Intensity and insults rise as lawmakers debate debt ceiling
Modern Day Options Trading For Beginners! (Ad)pixel
UK travelers face hours-long waits for ferries to France
Canada approves largest telecom deal in country's history
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
What is a Gold IRA, and is it a Viable Investment?
This Tech Stock Could be the Next Amazon (Ad)pixel
Closing prices for crude oil, gold and other commodities
MarketBeat Week in Review – 3/27 - 3/31
Modern Day Options Trading For Beginners! (Ad)pixel
UN body mulls deep sea mining amid demand for minerals
Intensity and insults rise as lawmakers debate debt ceiling
Modern Day Options Trading For Beginners! (Ad)pixel
UK travelers face hours-long waits for ferries to France
Canada approves largest telecom deal in country's history
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
What is a Gold IRA, and is it a Viable Investment?
This Tech Stock Could be the Next Amazon (Ad)pixel
Closing prices for crude oil, gold and other commodities
MarketBeat Week in Review – 3/27 - 3/31
Modern Day Options Trading For Beginners! (Ad)pixel
UN body mulls deep sea mining amid demand for minerals
Intensity and insults rise as lawmakers debate debt ceiling
Modern Day Options Trading For Beginners! (Ad)pixel
UK travelers face hours-long waits for ferries to France
Canada approves largest telecom deal in country's history
TSE:I

Intellipharmaceutics International - I Stock Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
C$3.23
C$3.23
52-Week Range
N/A
Volume
7,625 shs
Average Volume
16,872 shs
Market Capitalization
C$97.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Intellipharmaceutics International

Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. Based on this technology platform, it has developed various drug delivery systems and a pipeline of products, and product candidates in various stages of development, in therapeutic areas that include neurology and cardiovascular. Its pipeline of products includes Rexista Oxycodone, Regabatin XR, Generic Focalin XR, Generic Effexor XR, Generic Protonix, Generic Glucophage XR, Generic Seroquel XR, Generic Lamictal XR, Generic Keppra XR, Generic Pristiq and Generic Ranexa. Its generic product candidates also include Trazodone hydrochloride extended-release tablets and Carvedilol phosphate extended-release capsules.

Receive I Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intellipharmaceutics International and its competitors with MarketBeat's FREE daily newsletter.

I Stock News Headlines

Intellipharmaceutics International Inc. (IPCIF)
"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast.
Intellipharmaceutics International Inc
Stocks in play: Intellipharmaceutics International Inc.
"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast.
Intellipharmaceutics Announces Third Quarter 2021 Results
See More Headlines
Receive I Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intellipharmaceutics International and its competitors with MarketBeat's FREE daily newsletter.

I Company Calendar

Today
4/01/2023
Next Earnings (Estimated)
4/13/2023

Industry, Sector and Symbol

Industry
Wireless Telecommunications
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
1,195
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$97.40 million
Optionable
Optionable
Beta
N/A

Key Executives

  • Isa Odidi Ph.D.
    Chairman of the Board, Chief Executive Officer
  • Amina Odidi Ph.D.
    President, Chief Operating Officer, Director
  • Andrew Patient
    Chief Financial Officer
  • John N. Allport
    Vice President - Legal Affairs and Licensing, Secretary, Director
  • Patrick N. Yat Ph.D.
    Vice President - Pharmaceutical Analysis and Chemistry
  • Kenneth Keirstead
    Independent Director
  • Bahadur Madhani
    Independent Director
  • Eldon R. Smith M.D. (Age 75)
    Independent Director













I Stock - Frequently Asked Questions

When is Intellipharmaceutics International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 13th 2023.
View our I earnings forecast
.

What other stocks do shareholders of Intellipharmaceutics International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Intellipharmaceutics International investors own include QuickLogic (QUIK), VBI Vaccines (VBIV), NeuLion (NLN), Micron Technology (MU), Mallinckrodt (MNK), Intellipharmaceutics International (IPCIF), Fitbit (FIT), Clean Commodities (CLE), Calithera Biosciences (CALA) and BlackBerry (BB).

What is Intellipharmaceutics International's stock symbol?

Intellipharmaceutics International trades on the Toronto Stock Exchange (TSX) under the ticker symbol "I."

How do I buy shares of Intellipharmaceutics International?

Shares of I stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

How much money does Intellipharmaceutics International make?

Intellipharmaceutics International (TSE:I) has a market capitalization of C$0.00.

How many employees does Intellipharmaceutics International have?

The company employs 1,195 workers across the globe.

How can I contact Intellipharmaceutics International?

Intellipharmaceutics International's mailing address is 30 Worcester Rd, ETOBICOKE, ON M9W 5X2, Canada. The official website for the company is www.intelsat.com. The company can be reached via phone at +1-416-7983001.

This page (TSE:I) was last updated on 4/1/2023 by MarketBeat.com Staff